Gargoyle Investment Advisor L.L.C. held its stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 48,457 shares of the medical technology company’s stock at the end of the second quarter. Hill-Rom Holdings makes up approximately 1.5% of Gargoyle Investment Advisor L.L.C.’s portfolio, making the stock its 6th largest position. Gargoyle Investment Advisor L.L.C.’s holdings in Hill-Rom Holdings were worth $3,858,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of HRC. Capstone Asset Management Co. boosted its stake in shares of Hill-Rom Holdings by 2.0% in the first quarter. Capstone Asset Management Co. now owns 7,515 shares of the medical technology company’s stock valued at $531,000 after buying an additional 150 shares in the last quarter. Fox Run Management L.L.C. acquired a new stake in shares of Hill-Rom Holdings during the first quarter valued at $527,000. Louisiana State Employees Retirement System boosted its stake in shares of Hill-Rom Holdings by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 15,000 shares of the medical technology company’s stock valued at $1,059,000 after buying an additional 200 shares in the last quarter. Boston Advisors LLC boosted its stake in shares of Hill-Rom Holdings by 616.8% in the first quarter. Boston Advisors LLC now owns 212,210 shares of the medical technology company’s stock valued at $14,982,000 after buying an additional 182,605 shares in the last quarter. Finally, Nationwide Fund Advisors boosted its stake in shares of Hill-Rom Holdings by 135.8% in the first quarter. Nationwide Fund Advisors now owns 387,218 shares of the medical technology company’s stock valued at $27,338,000 after buying an additional 223,018 shares in the last quarter. 84.00% of the stock is currently owned by institutional investors.

Hill-Rom Holdings Inc (HRC) opened at 73.72 on Friday. Hill-Rom Holdings Inc has a 12-month low of $50.50 and a 12-month high of $84.65. The firm has a market cap of $4.86 billion, a price-to-earnings ratio of 42.96 and a beta of 1.22. The company has a 50-day moving average of $79.48 and a 200 day moving average of $72.76.

Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The company’s revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.81 earnings per share. Equities analysts expect that Hill-Rom Holdings Inc will post $3.82 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be given a $0.18 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.98%. Hill-Rom Holdings’s payout ratio is currently 41.62%.

TRADEMARK VIOLATION NOTICE: “Gargoyle Investment Advisor L.L.C. Has $3,858,000 Position in Hill-Rom Holdings Inc (HRC)” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/13/gargoyle-investment-advisor-l-l-c-has-3858000-position-in-hill-rom-holdings-inc-hrc.html.

Several analysts recently weighed in on HRC shares. Barclays PLC boosted their price objective on shares of Hill-Rom Holdings from $70.00 to $75.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 19th. Stifel Nicolaus boosted their price objective on shares of Hill-Rom Holdings from $70.00 to $84.00 and gave the stock a “buy” rating in a research note on Monday, May 1st. Zacks Investment Research cut shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Finally, ValuEngine raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $88.17.

In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of the company’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $72.30, for a total value of $150,239.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Andreas G. Frank sold 10,660 shares of the company’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total transaction of $838,089.20. Following the completion of the transaction, the senior vice president now owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.